Minimal differences shown by echocardiography and NT-proBNP level distinguishing cardiotoxic effect related to breast cancer therapy in patients with or without HER2 expression.
Event:
EuroEcho-Imaging 2016
Topic:
Effect of systemic illnesses on the heart
Session:
Cardiomyopathies
